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Electroacupuncture (EA), especially high-frequency EA, has frequently been used as an alternative therapy for Parkinson disease
(PD) and is reportedly eﬀective for alleviating motor symptoms in patients and PD models. However, the molecular mechanism
underlying its eﬀectiveness is not completely understood. To implement a full-scale search for the targets of 100Hz EA, we
selected rat models treated with 6-hydroxydopamine into the unilateral MFB, which mimic end-stage PD. High-throughput
microarray analysis was then used to uncover the regulated targets in the cortex and striatum after 4-week EA treatment. In
the diﬀerentially regulated transcripts, the proportion of recovered expression proﬁles in the genes, the functional categories of
targets in diﬀerent proﬁles, and the aﬀected pathways were analyzed. Our results suggested that the recovery of homeostasis in the
transcript network and many regulated functional clusters in the cortex and striatum after EA treatment may contribute to the
behavioral improvement of PD rats.
1.Introduction
Parkinson’s disease (PD) is an age-related neurodegenerative
disease that aﬀects about 1–3% of the population over 65
years of age and is characterized by the progressive loss of
DAergic neurons in the substantia nigra pars compacta and
an associated decline in striatal dopamine [1]. It is known
that “idiopathic” PD (>85% of all cases) does not appear to
exhibit heritability [2]. In addition, there is no cure for PD,
and the underlying pathogenesis of the disease is still un-
known [2]. In general, we understand that the pathology of
PD is complex and is most likely a “consequence of an un-
speciﬁed combination of genetic and environmental factors,
which induce a common pathogenic cascade of molecular
events”[3].Pharmacologicalandsurgicaltherapiesareavail-
able that can alleviate some of the symptoms, but these inter-
ventions are associated with serious side eﬀects and generally
lose their eﬃcacy over time [4]. Acupuncture, however, has
long been known to have therapeutic eﬀects on chronic and
acute pain. Today, electro-acupuncture (EA) is frequently
used as an alternative therapy for PD and reportedly leads to
subjective improvements in PD patients [5, 6]. An increas-
ingnumberofclinicalstudiesandexperimentaldatasupport
EA, especially high-frequency EA, as an eﬀective therapy for
alleviating motor symptoms in patients and PD models [7–
9]. However, the underlying neuroprotective mechanisms of
acupuncture treatment in PD are not yet understood. Some
experimental results reveal that EA could increase the num-
ber of tyrosine hydroxylase- (TH-) positive neurons in the
substantia nigra and striatum (STR) of an MPTP- (1-meth-
yl-4-phenyl-1,2,3,6-tetrahydropyridine-) treated mouse
model [10, 11]. Using the hemiparkinsonian rat model in-
duced by unilateral transection of the medial forebrain
bundle (MFB), our previous studies showed that 100Hz EA2 Evidence-Based Complementary and Alternative Medicine
could signiﬁcantly improve the apomorphine-induced mo-
tor disorder symptoms, but the dopamine (DA) content
did not increase signiﬁcantly [12, 13]. Moreover, the ef-
fects of high-frequency EA on the motor symptoms of
Parkinsonian rats involved the upregulation of endogenous
neurotrophins[8,9]andBDNFandtrkBreceptorsina6-hy-
droxydopamine- (6-OHDA-) induced rat PD model [14], as
well as the restoration of the homeostasis of DAergic trans-
missioninthebasalgangliacircuitandthesuppressionofin-
ﬂammatory responses in the ventral midbrain [9, 12, 15].
These results suggest that the mechanisms underlying the
beneﬁts of acupuncture are systemic and unknown. Thus, it
is especially important to ﬁnd EA-targeted transcripts. Gene
expression proﬁling using microarray technology could re
veal the complex nature of disease genesis and progression
[16] and the many targets of certain therapeutic measures
at the genomic level [17]. To search for EA-aﬀected tran-
scripts after 6-OHDA treatment and obtain insight into the
potential mechanism of EA’s eﬀect, we applied the microar
ray method to explore gene expression proﬁles in a control
group, a 6-OHDA-unilateral lesioned rat model, and an
EA-treated group for 4 weeks after 6-OHDA lesion. We ob
served the diﬀerential genes at the transcription level and
the changed gene proﬁles in the cortex and STR.
2.MaterialsandMethods
2.1.AnimalCareandUnilateralMFBInjectionwith6-OHDA.
Adult female Sprague Dawley rats weighing 200–220g
were obtained from the laboratory animal center, Capital
University of Medical Sciences, and housed in a standard 12-
ho n / o ﬀ light cycle with ad libitum access to food and water.
TheexperimentalprocedureswereapprovedbytheCommit-
tee on Animal Care and Usage, Capital Medical University,
and all eﬀorts were made to minimize animal suﬀering.
The artiﬁcial lesion with 6-OHDA into the MFB is con-
sidered an appropriate model to study late-stage PD [18].
After adapting to their surroundings for 3 days, SD rats were
anesthetized with chloral hydrate (350mg/kg, i.p.) and then
ﬁxed on a stereotaxic frame (David Kopf Instruments, Tu-
junga, CA, USA) with the mouth bar set at −3.3mm. The
skull was exposed, and a burr hole was drilled to introduce
a syringe for a single injection of the 6-OHDA solution
(containing 2µg 6-OHDA per µL in 0.01% ascorbicacid,
pH = 5). To minimize variability due to degradation of
the toxin, the 6-OHDA solutions were freshly made, kept
on ice, and protected from exposure to light. The solution
was injected into the left MFB according to the atlas of
K¨ onig and Klippel (1963); the coordinates relative to bregma
were ML: −2.5mm, AP: −3.8mm, and DV: −8.1mm. A
total volume of 4µL 6-OHDA was injected at a ﬂow rate of
1µL/min, and the syringe was leftin place for2min and then
slowly removed over a 1-2min time period. The skin was su-
tured, and then the animals received 4mg/kg ketofen i.p., as
an analgesic and were allowed to recover before returning
to the animal housing facilities. The lesion was allowed to
progress for 5 weeks, after which the animals were sacriﬁced
for postmortem analyses.
2.2. Behavioral Testing. Rotational testing was performed
blindlyandinautomaticrotameterbowls(ColumbusInstru-
ments, USA) prior to MFB lesion and 7 (one week), 14
(two weeks), and 35 days (5 weeks) following the lesion
(Figure 1(b)), a method previously reported by Liang et al.
[9]. Changes in rotational behavior were assessed by moni-
toring body rotations induced by apomorphine (0.5mg/kg,
s.c.). The net number of rotations (contralateral-ipsilateral)
was recorded over a time span of 45min, and the number of
turns per minute was calculated [13, 14, 19]. This behavioral
test was performed blindly. Data were reported as means
± SEM. Statistical signiﬁcance was assessed using one-way
ANOVA followed by the Newman-Keuls post hoc test of dif-
ferences between groups. A P<0.01 was considered statis-
tically signiﬁcant in this portion of the experiment.
2.3. High-Frequency EA Stimulation. EA stimulation at
100Hz was performed following our previously described
method [8, 9, 12]. Rats were randomly divided into three
groups: the sham group, the 6-OHDA-injected group, and
the 6-OHDA-injected group with EA stimulation at 100Hz.
Animals in the sham group underwent the same operation
without injection of 6-OHDA. EA stimulation was adminis-
tered from day 8 following the 6-OHDA injection after be-
havioral testing at one week. Two stainless steel needles
0.25mm in diameter and 5mm in length were inserted
obliquelyattheacupuncturepointDAZHUI(GV14,directly
below the spinous process of the vertebra prominens) and
horizontally at BAIHUI (GV 21, at the midpoint of the line
connectingthetwoears).Bidirectionalsquare-waveelectrical
pulses (0.2ms duration), designated EA, were administered
for a total of 30min each day, 6 days per week. The duration
of EA treatment was limited to 4 weeks. The intensity of the
stimulation was increased stepwise from 1 to 2mA and then
to 3mA, with each step lasting for 10min. The animals re-
mained in the cage during EA administration in an awake,
unrestrained condition.
2.4. Immunohistochemical Analysis. Rats were deeply anes-
thetized with 450mg/kg chloral hydrate and then transcar-
dially perfused with 100mL saline followed by 200mL 4%
paraformaldehyde in phosphate buﬀer. Brains were dissected
and postﬁxed in the same ﬁxative and cryoprotected in 30%
sucrose solution for 3–5 days. Frozen sections were cut into
30µm thick sections on a cryostat and processed for TH-
immunohistochemistry. Every sixth section of the SN or STR
was selected from each brain. After several washes, brain
slices were incubated with TH antibody (diluted 1:2000;
Chemicon, USA) for 24h at 4◦C. The antibody was detected
using an ABC Elite kit (Vector laboratories, USA) with 3, 3 -
diaminobenzidine (DAB) and nickel enhancement [13].
2.5. Protein Extraction and Western Blot. To obtain protein
extracts, rats were sacriﬁced by cervical dislocation 2 days
after the last electroacupuncture treatment, and each ence-
phalic region was dissected rapidly and frozen using liquid
nitrogen and kept at −80◦C until use. The frozen substantia
nigras were homogenized 4 times with sonication at 70%
intensity in 10s bursts with 500µL of routine SDS-proteinEvidence-Based Complementary and Alternative Medicine 3
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Figure 1:PDratmodelswerepreparedusing6-OHDAandweretreatedwith100HzEA.EAat100Hzwasappliedattheacupuncturepoints
DAZHUI (GV14) and BAIHUI (GV21) for 28 days. Rotational behavior induced by apomorphine was measured 1, 2, and 5 weeks after 6-
OHDA treatment of the MFB. (a) The Y-axis represents the net number of turns of rats per minute. The X-axis represents the detection
time. The net number of turns per minute of the 5-week EA-treated group decreased signiﬁcantly compared to the corresponding 5-week
model group (P<0.001). ((b) and (c)) Western blotting results revealed that the expression of TH was signiﬁcantly downregulated in the
right STR of the 6-OHDA-treated rats (MR) and the EA-treated model rats (ER) compared to the nonlesioned side (c). CL and CR represent
theleftandrightSTRofthecontrolrats,respectively. Therelativegreylevel ispresented in(b)(∗P<0.01).TheY-axisrepresents therelative
grey value versus the control. The X- a x i sr e p r e s e n t sd i ﬀerent groups. In addition, the extensive loss of DA neurons in the rat SN and STR was
detected using Tyrosine hydroxylase- (TH-) speciﬁc immunostaining (scale bar 2mm, (d)-(A)–(d)-(F)). As indicated by the arrows in (d),
representative microphotographs of the right STR ((d)-(E) and (d)-(F)) and SN ((d)-(B) and (d)-(C)) after TH immunostaining showed
an extensive reduction in the density of TH-immunoreactive axons in the STR and SN of 6-OHDA-treated rats, regardless of EA treatment
(right STR of (d)-(E) and (d)-(F) and right SN of (d)-(B) and (d)-(C)), compared to the control ((d)-(A) and (d)-(D) or the left of model
STR or SN).4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: The ﬂow-sheet was used for the data analysis of genomic proﬁle. Three biology duplicate samples in each group were used for
microarray analyzing. The cortex and right STR were examined, and the diﬀerential genes in this ﬁgure came from comparison of three
groups (P<0.05). To observe these genes in depth, STC (Figure 3) and pathway analysis were performed. Dividing diﬀerential genes into
groups according to 16 proﬁles by STC, we then completed a functional annotation (Tables 1–3, S1–4). Then, genes from the 6 types of
recovery expression proﬁles (A)–(F) after EA-treatment were subjected to Dynamic-GeneNet analysis. The genes of three proﬁles (STC (a),
(b), and (c)) were the principal part in the spatial network.
lysing buﬀer (including protease inhibitor cocktail, P2714,
Sigma). The protein concentration of the ﬁnal extract solu-
tion was determined using the BCA method. The western
blotting procedures followed the standard protocol. Protein
lysates were separated by electrophoresis and transferred to
nitrocellulose membranes. The membranes were blocked
with 5% nonfat dry milk in PBS containing 0.2% Tween
20 for 1h and then incubated overnight at 4◦C with the
indicated primary antibody. Membranes were then treated
withIRDye 800(green)orIRDye 700(red)conjugatedaﬃn-
ity puriﬁed anti-mouse, anti-rabbit secondary IgG for 1h,
followed by three washes with PBS containing 0.1% Tween
20 and two washes with PBS alone. The ﬂuorescent bands
were visualized using an LI-COR Odyssey infrared double-
ﬂuorescence imaging system (American Company LI-COR).
2.6.SamplePreparationandMicroarrayImageAnalysis. Total
RNA was separately extracted from the nine individual sam-
ples using the RNeasy Mini Kit (QIAGEN, 74106). Microar-
ray analysis was performed and repeated 3 times using a
biological sample in each group with the Whole Rat GenomeEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: STC analyzed for diﬀerential genes in the cortex and STR after 6-OHDA or 6-OHDA/EA treatment. There were 16 types of proﬁles
for diﬀerential genes in three experimental groups of the cortex or STR (control, model, and EA group). The number on the Y-axis is the
degree of change and not a concrete value. These proﬁles can be divided into 5 subgroups. (a) Recovery expression proﬁles group ((a),
(A)–(F)). After EA treatment, these genes tended to recover the normal level. Genes of (a)-(A) and (B) were completely recovered. Genes
of (a)-(C) and (D), however, were only partially recovered. (a)-(E) and (F) represent the overcorrect genes. (b) Upregulated group ((b),
(A)–(C)). These genes continued to be upregulated after EA treatment. (c) Downregulated group ((c), (A)–(C)). These genes continued
to be downregulated after EA treatment. These two part of genes ((b) and (c)) need to be considered individually and they belong to the
portion of genes regulated by EA. (d) This group was only regulated by EA ((d)-(A) and (d)-(B)). These genes were up- or downregulated
only after 100Hz EA treatment. (e) The group continued to maintain the model group level. These genes displayed no change after EA
treatment but were upregulated or downregulated compared to control. A detailed functional annotation is displayed (see Tables S2–8 in
supplementary material available on line at doi:10.1155/2012/908439) and it shows that the target genes of 100Hz EA are extensive and
involved in multifunctional regulation.
4 × 44K microarrays (Gene expression hybridization kit,
5188-5242,Agilent).FollowingtheprotocolsoftheLowRNA
Input Linear Ampliﬁcation and Labeling Kit Plus (Agilent,
#5184-3523), we synthesized double-stranded cDNA and
applied it as a template to label cRNA. For each hybridiza-
tion, 2µg of total RNA from each sample (control or
model) was used. Each sample cRNA (labeled with Cy3 (Cy3
NHS ester, PA13105 GE healthcare)) was individually hy-
bridized on microarrays. The labeling and hybridization
steps were carried out according to the Agilent protocol, and
the images were scanned using a microarray scanner (Ag-
ilent, G2565BA).
2.7. Mul-Class Dif Analysis. We applied the RVM F-test to
ﬁlter the diﬀerentially expressed genes in the control and ex-
periment group because the RVM F-test can eﬀectively6 Evidence-Based Complementary and Alternative Medicine
increase the degrees of freedom in cases of small samples.
After the signiﬁcance analysis and FDR analysis, we selected
the diﬀerentially expressed genes according to the P value
threshold [20, 21].
2.8. STC Analysis. The series test of cluster (STC) algorithm
of gene expression dynamics was used to proﬁle the gene ex-
pression time series and to identify the most probable set
of clusters generating the observed time series. This method
explicitly took into account the dynamic nature of the tem-
poral gene expression proﬁles during clustering and iden-
tiﬁed the number of distinct clusters [22, 23].
We selected diﬀerential expression genes in a logical se-
quence according to RVM (Random variance model) correc-
tive ANOVA. In accordance with the diﬀerent signal densi-
ty change proﬁles of genes under diﬀerent conditions, we id-
entify a set of unique model expression proﬁles. The raw
expression values were converted into log2 ratios. Using a
strategy for clustering short time-series gene expression data,
we deﬁned a set of unique proﬁles. The expression mo-
del proﬁles are related to the actual or expected number of
genesassignedtoeachmodelproﬁle.Signiﬁcantproﬁleshave
higher probability than expected by Fisher’s exact test and
multiple comparison test [24].
2.9. STC-Gene Functional Annotation. For transcripts in
each proﬁle of STC analysis, functional annotation and clas-
siﬁcation were completed using DAVID 6.7b (current re-
lease, Jan. 2010) of DAVID Bioinformatics Resources (http://
david.abcc.ncifcrf.gov/)[ 25, 26]. Functional annotation is
applied to the genes belonging to certain speciﬁc proﬁles. It
is used to ﬁnd the main function of the genes with the same
expression trend. Gene ontology (GO) is a key functional
classiﬁcation of DAVID.
2.10. Dynamic-GeneNet (Coexpression Network). We also
construct gene coexpression networks to ﬁnd the interac-
tions among genes in selected STC proﬁles (Figure 3(a),(A)–
(F)) [27]. Gene coexpression networks were built according
to the normalized signal intensity of speciﬁc expression
genes. For each pair of genes, we calculated the Pearson cor-
relation and chose the signiﬁcant correlation pairs to con-
struct the network (Figure1S) [28].
In the networkanalysis,the degree centrality is one ofthe
simplest and most important measures of the centrality of a
gene and its relative importance within a network. Degree
centrality is deﬁned as the number of links that one node
has to all of the other nodes [29]. Moreover, in studying
some properties of the networks, k-cores in graph theory
were introduced as a method of simplifying the analysis of
graph topologies. A k-core of a network is a subnetwork in
which all nodes are connected to at least k other genes in the
subnetwork. A k-core of a protein-protein interaction net-
work usually contains cohesive groups of proteins [29].
The purpose of Network Structure Analysis is to locate
core regulatory factors (genes), in one network. Core regula-
tory factors connect the most adjacent genes and have the
largest degrees. When considering diﬀerent networks, the
core regulatory factors were determined by the degree of dif-
ference between two class samples [30] .T h ec o r er e g u l a t o r y
factorsalwayshavethelargestdegreediﬀerences.Thedistinct
ﬁgures of our coexpression network comprising the selected
genes are shown in Figures S1A and B.
2.11. Pathway Analysis. Similarly, pathway analysis was used
to determine the signiﬁcant pathway of the diﬀerential genes
accordingtoKEGG,Biocarta,andReatome.WeusedFisher’s
exact test and the chi-square test to select the signiﬁcant
pathway, and the threshold of signiﬁcance was deﬁned by
the P value and FDR. The enrichment was calculated as pre-
viously described [31–33].
2.12. Clustering and TreeView for Identiﬁed Transcripts.
HierarchicalclusteringwasperformedinCluster3.0soft.For
nine samples (Cortex or STR), a list was prepared of the
selected genes to be clustered. The normal signal data for
s e l e c t e dg e n e sw e r ea d j u s t e dt ob e c o m el o gt r a n s f o r md a t a .
Then the data were arranged according the requirements of
Cluster 3.0 and “median” was selected for center genes and
arrays. After that, the results of clustering of selected genes
were presented by Java TreeView and exported to the images.
2.13. Selected Gene Expression Changes Were Validated Using
qRT-PCR. Total RNA was extracted from the cortex or STR
using a standard trizol (Invitrogen, 15596-018) procedure
from each tissue sample. RNA was treated with RNase-free
DNase I, and 3µg of total RNA was subjected to cDNA syn-
thesis with M-MLV reverse transcriptase (Promega, M170)
in a 30 µL liquid phase reaction for RT-PCR, from which
1µL of cDNA was used for PCR ampliﬁcation. The primers
used as an internal control for RT-PCR to amplify human
18S were 5 -GGAAGGGCACCACCAGGAGT and 5 -TGC
AGCCCCGGACATCTAAG. The primers used for amplify-
ing 6-OHDA-targeted RNAs in real-time PCR (Stratagene
MX3000P Sequence Detection system, USA) are listed in
Table S1 (Supplementary Materials). The trials were com-
pleted by SYBR Premix Ex Taq kit (Takara, DRR041B). The
PCR protocol consisted of 1min at 95◦Cf o l l o w e db y4 0
cycles of 30s at 95◦C, 30s at 55◦C, and 1min at 72◦C
(Figure 4(b)) .T h el e v e l so ft a r g e tg e n ee x p r e s s i o nw e r e
quantiﬁed relative to the level of 18S using the standard
curve method. The speciﬁcities of RT-PCR products were
conﬁrmed by the presence of both a single dissociation
curve for the product and a single band, with corresponding
molecularweightrevealedbyagarosegelelectrophoresis.The
statistical signiﬁcance of the cluster gene rate and the discrete
ratewasassessedusingt-test.AP value<0.05wasconsidered
statistically signiﬁcant.
3. Results
3.1. EA at 100Hz Attenuated the Rotational Behavior in a
6-OHDA PD Model. As seen in Figure 1,an e a r l yc o m p l e t e
denervation of the SN in a rat model was observed in our ex-
periments (Figures 1(d)-(B) and 1(d)-(E)). As hypothesized,
the high-frequency EA stimulation did not to prevent the
reduction in TH-positive dendritic ﬁbers in the lesion-lateralEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Selected transcripts clustered and validated with real-time PCR. After pathway analysis, we selected genes involved in major
pathways (the common pathways in the cortex and STR, Table 7). First, selected genes were clustered using Cluster 3.0 according to the LOG
value in the STR groups (a) Red is relatively upregulated and green is relatively downregulated in diﬀerent samples. The three “Cs” are the
three control samples. The three “Ms” are the model samples. The three “Es” are the EA-treated samples. Then, to verify the reliability of the
microarray analysis, we veriﬁed these selected genes from the clustering diagram using real-time RT-PCR. The real-time PCR primers are
listed on Table S1 (devised and synthesized by Takara). The reaction procedure was present on (b). If the level of control was regarded as 1,
the corresponding gene expression in model and EA-treated groups were present on (c). These transcripts analyzed here showed coherent
proﬁles with cluster (a).
SN and STR (Figures 1(d)-(C) and 1(d)-(F)). Howev-
er, EA stimulation at 100Hz reduced the number of rota
tions exhibited by the unilaterally 6-OHDA lesioned PD mo-
dels (Figure 1(a)). The rotational behavior induced by apo-
morphine (0.5mg/kg) was measured 1 (7 days), 2 (14 days),
and 5 weeks (35 days) after the 6-OHDA-treatment of
the MFB. The net number of turns was calculated as
the number of contralateral turns minus the number of
ipsilateral turns. The values are expressed as means ± SEM
(n = 10–14 per group, P<0.01 between model/EA group
and control). The turns/min of the control group was
0.42 ± 0.28 turns/min for 1 week, 0.33 ± 0.12 turns/min
for 2 weeks and 0.43 ± 0.19 turns/min for 5 weeks. The rats
in the 6-OHDA-treated group exhibited greater rotational
asymmetry in the direction contralateral to the lesion
(9.52 ± 1.69 turns/min at 1 weeks; 8.24 ± 2.10 turns/min at
2 weeks; and 12.44 ± 1.94 turns/min at 5 weeks) compared
to the rats in the EA-treated group (9.13 ± 2.65 turns/min
for 1 week; 7.88 ± 2.3 0t u r n s / m i nf o r2w e e k s ;6 .92 ± 1.98
turns/min for 5 weeks). The number of turns of the 5-week
EA-treated group decreased signiﬁcantly compared to the
corresponding 5-week model group (P<0.001, the results
from week 1 and week 5 are presented in Figure 1(a)). These
results revealed that the number of apomorphine-induced
rotations exhibited by 6-OHDA PD rats is reduced after EA
treatment, although a histological recovery to normal levels
could not be identiﬁed.
3.2. EA at 100 Hz Caused a Multimolecular Change In Vivo.
An ANOVA for the three groups (Control, Model and EA
group) in our studies revealed that there were 2371 diﬀeren-
tial genes in the cortex and 1093 diﬀerential genes in the STR
(P<0.05, Figure 2). After the STC analysis, these diﬀeren-
tial genes were divided into 16 types of expression proﬁles
according to the alignment of the control, model, and EA-
treated groups (Figure 3). The transcripts in proﬁle (a)
showed that the eﬀect of EA in 6-OHDA lesioned animals
return to the proximalis levels of gene expression that were8 Evidence-Based Complementary and Alternative Medicine
observed in the control group. The functional annotations
for these transcripts in the 16 proﬁles refer to Tables S2–8
(Supplementary Material). Among the results of the func-
tional annotations, the majority of the regulated genes be-
longed to proﬁle (a) (recovered), (b) (upregulated), (c)
(downregulated), or (e) (sustained) after EA treatment. The
functions of these transcripts were found to be involved in
manyaspects,whichwerepresentedinsupplementaryTables
S2–5 and Tables S7–8, after DAVID 6.7 analysis. Therefore,
100Hz EA may cause a multimolecular change in vivo in a
PD model.
In addition, our results reveal that there were 255 mutual
genes, with 16 types of proﬁles between the cortex and STR,
and that 87.06 percent of these genes (222/255) were in the
noncontradicted proﬁles (proﬁles in addition to the opposite
regulated genes by EA). After the DAVID 6.7 analysis, 74.36
percent of the genes (29/39) listed in Table S9, which had
names and functional annotations, belonged to the genes in
proﬁle(a)ofFigure 3.Afterthefunctionalannotationforthe
genes in Table S9, the categories of “cognition and sensory
perception,” “olfactory transduction and receptor activity,”
“G-protein coupled receptor protein signaling pathway,”
“integral to membrane,” and “neurological system process”
were found to be regulated by high-frequency EA (P ≤ 0.01,
TableS10).Multipletranscriptsofthesefunctionalcategories
t r e n d e dt o w a r dr e c o v e r yt on o r m a ll e v e l s( T a b l eS 9 ) .
The identiﬁcation of the signiﬁcantly regulated genes
(the log2 diﬀerence absolute ≥ 1c o m p a r e dt om o d e l ,P<
0.05) after EA treatment was important to explain the inter-
nal changes to disorder and turnover of the genes. According
to the standard in the previous bracket, 71 genes in the
cortex were selected, and 50 genes, or 70.42% (50/71), were
in proﬁle (a) of Figure 3 (Table S11). In addition, 38 genes in
the STR were selected, of which 78.95%, or 30 genes, were in
proﬁle (a) of Figure 3. The notations of these genes are listed
in Table S11. This table shows which transcripts belong to
each proﬁle.
3.3. Multipathways Targeted by 100Hz EA. The following ten
pathways in the cortex and nine pathways in the STR were
predominantly aﬀected by 100Hz EA (P<0.05, Table S12):
the olfactory transduction pathway (P<0.001), Alzheimer’s
disease pathway (P<0.001), Huntington’s disease pathway
(P<0.001),neuroactiveligand-receptorinteractionpathway
(P<0.001), inositol phosphate metabolism pathway (P<
0.01), calcium signaling pathway (P<0.05), systemic lupus
erythematosus pathway (P<0.05), amyotrophic lateral
sclerosis (ALS) pathway (P<0.05), p53 signaling pathway
(P<0.05), and long-term depression pathway (P<0.05)
in the cortex; the neuroactive ligand-receptor interaction
pathway (P<0.01), olfactory transduction pathway (P<
0.01), arachidonic acid metabolism pathway (P<0.01),
amyotrophic lateral sclerosis (ALS) pathway (P<0.05),
long-term depression pathway (P<0.05), ECM-receptor
interaction pathway (P<0.05), taurine and hypotaurine
metabolism pathway (P<0.05), cytokine-cytokine receptor
interaction pathway (P<0.05), and MAPK signaling
pathway (P<0.05) in the lesion-lateral STR (Table S12).
To validate the microarray results, we selected several
transcripts to cluster (Figure 4(a)) that were involved in ma-
jor pathways (Table S12) and validated the clustering result
using real-time PCR (Figure 4(c)). The functions of the pro-
tein products for these transcripts are listed in Table S13. To
some extent, theidentiﬁed resultsconﬁrmed thereliability of
the array analysis.
3.4. Internal Molecule Network Targeted by 100Hz EA. The
integrity coexpression network for the six recovered proﬁles
of the cortex and STR is presented in Figure S1. The simpli-
ﬁed network is shown in Figure 5 (genes without names or
with poor interactions were deleted). Combining these ﬁg-
ures, the network density and nodes’ degrees suggested that
the cortex assumes a more important role in the regulation
of internal balance after EA treatment. As seen in Figure
S1 and Figure 5, FAD104 (FNDC3B, XM 226988, degree =
42), olfactory receptor 192 (OLR192, NM 001000549, de-
gree = 40), basic helix-loop-helix domain containing class
B5 (BHLHB5, XM 345190, degree = 32), otopetrin 1
(OTOP1, NM 181433, degree = 32), and endothelin recep-
tor type A (ENDRA, NM 012550, degree = 31) are the core
nodes in the cortex network. Mitochondrial protease pre-
senilins-associated rhomboid-like protein (PARL/PSARL,
ENSRNOT00000030837, degree = 20), olfactory receptor
522 (OLR522, NM 001000562, degree = 18), and member
4a1 of the solute carrier organic anion transporter family
(SLCO4A1, NM 133608, degree = 15) are the most impor-
tant nodes in the impaired STR network.
4. Discussion
Acupuncture is a popular alternative therapy in patients with
Parkinson’s disease (PD) and may provide beneﬁt in the clin-
ical setting [34]. Although acupuncture has not been used to
cure PD, a survey of PD patients demonstrated that patients
who received acupuncture reported an improvement in their
symptoms [7]. In addition, acupuncture is very safe and
well tolerated in clinical practice. However, the mechanisms
underlying the neuroprotective eﬀects of this technique are
not yet clear.
The best course of PD therapy may be to increase the DA
content of the striatum. However, increasing evidence sug-
gests that a poor relationship exists between the dopamine
content of the striatum and the improvement of motor sym-
ptoms during PD treatment [35, 36]. Recently, Park et al.
reported that the mechanism of acupuncture involves mul-
tiple factors [10, 11, 17]. In addition, it has been argued
that DA neurons and other cells within the SN and adjacent
brain regions are involved in PD pathology [37, 38]. Our
results and those of work aiming to quantify the eﬀects of EA
demonstrate that the eﬀects may be produced by the coor-
dination of several internal brain regions including cortex
and STR.
To treat the neurochemical phenomenon of dopamine
depletion, we aimed to identify the molecular eﬀects of EA.
Arodentmodelwith6-OHDAinjectedintotheMFBmimics
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Figure 5: Simpliﬁed dynamic gene network for genes in proﬁle of Figure 3(a). The global dynamic gene networks of the cortex and STR are
shown in Figures S1A and S1B. A simpliﬁed network is presented here with the genes without names or some minor genes in the network
deleted. The blue dots indicate the diﬀerentially regulated genes. The lines show the relationship between genes. The solid line denotes
positive regulation, and the dashed line denotes negative regulation. The size of the dots indicates the capability of the gene to interact with
others, quantiﬁed by “degree” (refer to Section 2). The larger the degree, the more the genes interacted with the corresponding genes and
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an animal after amphetamine administration can be used to
distinguish between partial and near complete (>90%) den-
ervation in the SN [18]. Thus, a nearly complete denervation
in the SN of a rat model was observed in our experiments
(Figure 1(d)). Previously, we demonstrated that long-term,
high-frequency EA stimulation on the points of DAZHUI
(GV 14) and BAIHUI (GV 21) attenuated the rotational
behavior of PD rats with partial lesions and improved motor
activity [8, 9, 12]. In addition, previous results suggest that
the eﬀects of EA may be multitargeted and may be eﬀective
at PD without increasing dopamine (DA) [12, 13]. Thus, the
6-OHDA-injected rat model may provide an opportunity to
test how the cortex and lesion-lateral STR develop a con-
certed reaction and change after EA treatment. High-fre-
quency EA may also attenuate the rotational behavior of
the end-stage PD models without signiﬁcantly increasing the
number of TH-positive dendritic ﬁbers in the lesion-lateral
SN and STR (Figures 1(a) and 1(d)). The network regulation
of the central nervous system (CNS) and endocrine system
may also be involved in the mechanism of EA at PD.
At present, PD is no longer believed to be a disorder that
only aﬀects the DAergic system [35, 36]. The elucidation of
important gene expression proﬁles will enable the identiﬁca-
tion of genetic susceptibility markers, biomarkers of disease
progression, and new therapeutic targets [3]. According to
the standard of FCA ≥ 3 (EA versus model; log2 diﬀerence
absolute ≥ 1), ≥70% of the genes in the cortex and STR were
in proﬁle (a) of Figure 3 (Table S11). Lesions induced by 6-
OHDAmayactivateacompensatorycascadeofneurotrophic
activity within the nigrostriatal system as a physiological re-
sponse to the loss of DAergic neurons in rats [39, 40]. These
percentages also suggest that the eﬀect of EA in 6-OHDA
lesioned animals may result in a return of the partial gene
expression levels to those of control values. FCA ≥ 3t r a n -
scripts that can be searched for in the literature were listed
in Table S13. References to the functions of these transcripts
in the supplementary literature 1–4 indicate that the stable
expression of these transcripts is important for homeostasis.
In addition, several of the transcripts that were signif-
icantly regulated only by EA were particularly noteworthy
(Table S6, proﬁle (d) in Figure 3). EA at 100Hz upregulated
the functions of “epidermal growth factor receptor binding”
in the cortex and of “angiogenesis or vasculature develop-
ment” in the STR (P ≤ 0.01). AREG and EPGN partic-
ipated in the function of epidermal growth factor receptor
binding. TBX4, ANGPT2, and VEGFA (Table3) participated
in angiogenesis or vasculature development. The concrete
functions of these transcripts are shown in Table S13 referred
to the supplementary literature 5–9. These genes that were
upregulated by EA (Table S6) were extremely important for
angiogenesis or vasculature development, which contributes
to the delivery of important signal molecules from the cortex
to the STR or other regions.
After the relative expression level, which is either up- or
downregulated, was quantiﬁed, the altered transcripts were
appliedtoabioinformaticsanalysisusingtheprogram“path-
way” (Section 2). Ten pathways in the cortex and nine path-
ways in the STR were predominantly aﬀected by 100Hz
EA (Section 3). The most commonly regulated pathways
between the two encephalic regions included the olfactory
transduction pathway, neuroactive ligand-receptor interac-
tion pathway, amyotrophic lateral sclerosis (ALS) pathway,
and long-term depression pathway. PD is a neurodegener-
ative disease characterized by the selective degeneration of
DAergic cells in the SN and the nigrostriatal pathway. In the
6-OHDA-induced PD rat model, cotransplantation of fetal
ventral mesencephalic cells with olfactory ensheathing cells
(OECs) has been reported to enhance DA neuron survival,
striatal reinnervation, and functional recovery [41]. OECs
constitute a unique population of glial cells that accompany
and ensheath the primary olfactory axons. These cells are be-
lieved to be critical for the spontaneous growth of olfactory
axons within the developing and adult olfactory nervous sys-
tem and have recently emerged as potential candidates for
the cell-mediated repair of neural injuries [42]. However,
the relationship between the olfactory transduction pathway
and OECs has not yet been identiﬁed. Another important
regulatedpathwaybyEAwastheneuroactiveligand-receptor
interaction pathway. The signal connection was signiﬁcantly
enhanced in the cortex and in the lesion-lateral STR. The
pathway analysis for the diﬀerential regulated genes and the
functional annotation for the diﬀerential transcripts in the
regulated proﬁles by 100Hz EA suggest that EA functions
through network regulation. In addition, we selected several
transcripts in the commonly regulated pathways to identify
their expressions using QRT-PCR (Figure 4(c)). Several con-
crete functions of these transcripts are shown on Table S13
referred to the literature 10–13. From the corresponding lit-
erature, pathways related to hormone levels and inﬂamma-
tory stimuli may be targets of EA at 100Hz.
Multiple microarray studies have compared the gene ex-
pression proﬁles of cells within the midbrain of normal con-
trols with those from Parkinson’s diseased brains [37, 38, 43–
45]. As Section 3 presents, the diﬀerential genes were divided
into 16 types of expression proﬁles after the STC analysis
(Figure 3). Transcripts in proﬁle (a) revealed that the eﬀect
of EA in the 6-OHDA lesioned animals is to return the
levels of gene expression to control values. By summarizing
the functional annotations for these transcripts in the 16
proﬁles (Supplementary Tables S2–8), we were able to draw
a schematic to present the probable relationship between the
cortex and lesion-lateral STR (Figure 6). Several important
functional categories were identiﬁed in this schematic. In the
mutual functional clusters in the cortex and lesion-lateral
STR of proﬁle (a), the categories of “olfactory transduction
and receptor activity,” “G-protein coupled receptor protein
signaling,”“cognitionandsensoryperception,”“neurological
system process,” and “integral to membrane” were the func-
tional categories of the mutual regulated transcripts between
the cortex and STR (Table S10). The identical results of
the two diﬀerential analytic process revealed that there were
several functional clusters in the cortex and lesion-lateral
STR that are targeted by EA at 100Hz. In addition, the tran-
scripts in these functional clusters returned the levels of gene
expression to control values. These clusters were connected
vinculums between the cortex and lesion-lateral STR.
Although we observed a therapeutic eﬀect of high-fre-
quency EA, it was essential to explain the possible molecularEvidence-Based Complementary and Alternative Medicine 11
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Figure 6: A scheme of functional annotation for transcripts in the 16 types of proﬁles (for discussion). There were 16 types of proﬁles for the
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mechanism. Previously, no detailed and complete informa-
tion was available about how genes in the cortex and STR
wereregulatedbyEAtomaintainhomeostasis.Inthepresent
work, we observed that the transcriptional levels of many
functional clusters were regulated in the cortex or lesion-
lateral STR when DAergic neurons were nearly inactivated.
In addition, the functions of these transcripts were found to
be involved in many aspects (shown in supplementary Tables
S2–8). Our results also suggest that lesions induced by 6-
OHDA may activate a compensatory cascade, as described
above. Previously, microglial activation was observed in the
lesion-lateral SN of PD rat models, and 100Hz EA was
observed to signiﬁcantly inhibit the activation of microglia
in the SN [15]. In the present study, many transcripts, which
can positively regulate functions related to immune system
processes and immune responses, were downregulated in
the model cortex and were further downregulated after EA
treatment (Table S5, Figures 3(c) and 6). These ﬁndings
suggest that the immune suppression signal from the cortex
was present after the 6-OHDA lesion, possibly because of
a compensatory cascade. However, EA was able to further
enrich the suppressive signal. The relationship between the
suppressive signal and the two encephalic regions needs to
be investigated further.
High-frequencyEAresultedinareductioninthenumber
of apomorphine-induced rotations. We also found that EA
resulted in the up- or downregulation of several other func-
tions in the two encephalic regions (Figure 6). Combining12 Evidence-Based Complementary and Alternative Medicine
the functional categories for the recovery proﬁles, these clus-
ters form a functional network for the cortex and lesion-
lateralSTR,whichisregulatedby100HzEA.Inaddition, the
functional category of “response to hormone or endogenous
stimulus” in the lesion-lateral STR is interesting. The tran-
scripts in this functional cluster were downregulated. The
level of one transcript, prolactin (PRL),is known to be below
thedetectionlimitinPDpatients[46]andwasalsoextremely
low in our results (Figure 4(c)). EA at 100Hz was unable
to upregulated the level of PRL (Table S9). However, several
transcripts that respond to hormones or endogenous stimuli
were downregulated. The eﬀect mechanisms underlying the
phenomenon about the downregulated transcripts need to
be investigated further. Moreover, the coexpression network
of the transcripts in the six recovered proﬁles (Figure 3(a))
of the cortex and STR that were targeted by 100Hz EA is
p r e s e n t e di nF i g u r eS 1 .a n dFigure 5. By carefully observing
the transcripts in the networks, we identiﬁed that FAD104,
OLR192, BHLHB5, OTOP1, and ENDRA are the core nodes
in the targeted cortex network (degree ≥ 30). PSARL,
OLR522, and SLCO4A1 are the most important nodes
in the lesion-lateral STR network targeted by 100Hz EA.
The major functions of the eight transcripts are shown in
Table S13 referred to the supplementary literature 14–26.
Combining these ﬁgures, the network density and nodes’
degrees suggested that the cortex assumes the most impor-
tant role in the regulation of internal balance after EA treat-
ment (Figure 5). In addition, the cortex may be the center
that gives the regulation signal. To some extent, the most
commonlypresentedtranscriptsbetweenthecortexandSTR
and the proﬁles of these transcripts in three groups may
reﬂect the main trends of molecular regulation in vivo after
EA treatment. Furthermore, we analyzed the recovered gene
rate of the mutually presented genes between the cortex and
STR and the rate of the regulated transcripts (log2 > 1o r
log2 < −1). Both of these rates were greater than 70% (see
Section 3). A dynamic gene network including several of
these genes, especially genes in proﬁles (a)-(A), (C), and (E),
may be one part of the basic framework for high-frequency
EA eﬀects (Table S2, Figures 3, 5,a n d6).
Although information at the transcriptional level does
not directly correlate with the levels and functions of the cor-
responding proteins, transcription is the ﬁrst response and
defense when an organism is subjected to a stimulus. As a re-
sult, changes in global transcripts may reveal the molecular
mechanism of complicated disorders after high-frequency
EA treatment.
5. Conclusions
High-frequency EA may attenuate the rotational behavior of
a PD model when there was a near complete (>90%) den-
ervation in the lesion-lateral SN. A microarray analysis of
the cortex and STR revealed that 100Hz EA is a multitarget
treatment for PD and that the curative eﬀect may be gen-
eratedthroughregulatingtargetedtranscripts,pathways,and
functional clusters and through the spatial network inter-
action of targeted transcripts in diﬀerent encephalic regions.
In conclusion, recovering homeostasis may be an important
part of high-frequency EA mechanisms.
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